Candesartan Cilexetil / Hydrochlorothiazide Combination Tablets Special Drug Use Surveillance: Long-term Use (12 Months)
Status:
Completed
Trial end date:
2012-09-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of long-term use of
candesartan cilexetil / hydrochlorothiazide combination tablets (ECARD) Combination Tablets
LD&HD in hypertensive patients in the routine clinical setting